{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:54:35Z","timestamp":1791255275520,"version":"4.1.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1093\/brain\/awh068","type":"journal-article","created":{"date-parts":[[2004,2,27]],"date-time":"2004-02-27T15:13:48Z","timestamp":1077894828000},"page":"616-627","source":"Crossref","is-referenced-by-count":229,"title":["Blood\u2013brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis"],"prefix":"10.1093","volume":"127","author":[{"given":"S.","family":"Floris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. L. A.","family":"Blezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Schreibelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"D\u00f6pp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M. A.","family":"van der Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. L.","family":"Schadee\u2010Eestermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. D.","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. E.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,3]]},"reference":[{"key":"key\n\t\t\t\t20170624054836_AWH068C1","doi-asserted-by":"crossref","unstructured":"AlOmaishi J, Bashir R, Gendelman HE. The cellular immunology of multiple sclerosis. J Leukoc Biol1999; 65: 444\u201352.","DOI":"10.1002\/jlb.65.4.444"},{"key":"key\n\t\t\t\t20170624054836_AWH068C2","doi-asserted-by":"crossref","unstructured":"Anzai Y, Blackwell KE, Hirschowitz SL, Rogers JW, Sato Y, Yuh WT, et al. Initial clinical experience with dextran\u2010coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology1994; 192: 709\u201315.","DOI":"10.1148\/radiology.192.3.7520182"},{"key":"key\n\t\t\t\t20170624054836_AWH068C3","doi-asserted-by":"crossref","unstructured":"Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA Jr. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med1993; 177: 57\u201368.","DOI":"10.1084\/jem.177.1.57"},{"key":"key\n\t\t\t\t20170624054836_AWH068C4","doi-asserted-by":"crossref","unstructured":"Bauer J, Berkenbosch F, Van Dam AM, Dijkstra CD. Demonstration of interleukin\u20101 beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. J Neuroimmunol1993; 48: 13\u201321.","DOI":"10.1016\/0165-5728(93)90053-2"},{"key":"key\n\t\t\t\t20170624054836_AWH068C5","doi-asserted-by":"crossref","unstructured":"Brocke S, Piercy C, Steinman L, Weissman IL, Veromaa T. Antibodies to CD44 and integrin alpha4, but not L\u2010selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci USA1999; 96: 6896\u20136901.","DOI":"10.1073\/pnas.96.12.6896"},{"key":"key\n\t\t\t\t20170624054836_AWH068C6","doi-asserted-by":"crossref","unstructured":"Br\u00fcck W, Sommermeier N, Bergmann M, Zettl U, Goebel HH, Kretzschmar HA, et al. Macrophages in multiple sclerosis. Immunobiology1996; 195: 588\u2013600.","DOI":"10.1016\/S0171-2985(96)80024-6"},{"key":"key\n\t\t\t\t20170624054836_AWH068C7","doi-asserted-by":"crossref","unstructured":"Br\u00fcck W, Bitsch A, Kolenda H, Br\u00fcck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol1997; 42: 783\u201393.","DOI":"10.1002\/ana.410420515"},{"key":"key\n\t\t\t\t20170624054836_AWH068C8","unstructured":"Burstone MS. Histochemical comparison of naphtol\u2010phosphates for the demonstration of phosphates. J Nat Cancer Inst 1958; 20: 601."},{"key":"key\n\t\t\t\t20170624054836_AWH068C9","doi-asserted-by":"crossref","unstructured":"Corsini E, Gelati M, Dufour A, Massa G, Nespolo A, Ciusani E, et al. Effects of beta\u2010IFN\u20101b treatment in multiple sclerosis patients on adhesion between PBMNCs, HUVECs and MS\u2010HBECs: an in vivo and in vitro study. J Neuroimmunol1997; 79: 76\u201383.","DOI":"10.1016\/S0165-5728(97)00114-8"},{"key":"key\n\t\t\t\t20170624054836_AWH068C10","unstructured":"DeVries HE, Kuiper J, de Boer AG, Van Berkel TJ, Breimer DD. The blood\u2010brain barrier in neuroinflammatory diseases. Pharmacol Rev1997; 49: 143\u201355."},{"key":"key\n\t\t\t\t20170624054836_AWH068C11","doi-asserted-by":"crossref","unstructured":"Dijkstra CD, Dopp EA, van den Berg TK, Damoiseaux JG. Monoclonal antibodies against rat macrophages. J Immunol Methods1994; 174: 21\u20133.","DOI":"10.1016\/0022-1759(94)90006-X"},{"key":"key\n\t\t\t\t20170624054836_AWH068C12","unstructured":"Dousset V, Ballarino L, Delalande C, Coussemacq M, Canioni P, Petry KG, et al. Comparison of ultrasmall particles of iron oxide (USPIO)\u2010enhanced T2\u2010 weighted, conventional T2\u2010weighted, and gadolinium\u2010enhanced T1\u2010weighted MR images in rats with experimental autoimmune encephalomyelitis. AJNR Am J Neuroradiol1999a; 20: 223\u20137."},{"key":"key\n\t\t\t\t20170624054836_AWH068C13","doi-asserted-by":"crossref","unstructured":"Dousset V, Delalande C, Ballarino L, Quesson B, Seilhan D, Coussemacq M, et al. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med1999b; 41: 329\u201333.","DOI":"10.1002\/(SICI)1522-2594(199902)41:2<329::AID-MRM17>3.0.CO;2-Z"},{"key":"key\n\t\t\t\t20170624054836_AWH068C14","doi-asserted-by":"crossref","unstructured":"Dousset V, Gomez C, Petry KG, Delalande C, Caille JM. Dose and scanning delay using USPIO for central nervous system macrophage imaging. MAGMA1999c; 8: 185\u20139.","DOI":"10.1007\/BF02594597"},{"key":"key\n\t\t\t\t20170624054836_AWH068C15","doi-asserted-by":"crossref","unstructured":"Dousset V, Doche B, Petry KG, Brochet B, Delalande C, Caille JM. Correlation between clinical status and macrophage activity imaging in the central nervous system of rats. Acad Radiol2002; 9 Suppl 1: S156\u20109.","DOI":"10.1016\/S1076-6332(03)80426-9"},{"key":"key\n\t\t\t\t20170624054836_AWH068C16","doi-asserted-by":"crossref","unstructured":"Engelhardt B, Laschinger M, Schulz M, Samulowitz U, Vestweber D, Hoch G. The development of experimental autoimmune encephalomyelitis in the mouse requires \u03b14\u2010integrin but not \u03b14\u03b27\u2010integrin. J Clin Invest1998; 102: 2096\u2013105.","DOI":"10.1172\/JCI4271"},{"key":"key\n\t\t\t\t20170624054836_AWH068C17","doi-asserted-by":"crossref","unstructured":"Ewing C, Bernard CC. Insights into the aetiology and pathogenesis of multiple sclerosis. Immunol Cell Biol 1998; 76: 47\u201354.","DOI":"10.1046\/j.1440-1711.1998.00718.x"},{"key":"key\n\t\t\t\t20170624054836_AWH068C18","doi-asserted-by":"crossref","unstructured":"Filippi M, Dousset V, McFarland HF, Miller DH, Grossman RI. Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: consensus report of the White Matter Study Group. J Magn Reson Imaging2002; 15: 499\u2013504.","DOI":"10.1002\/jmri.10097"},{"key":"key\n\t\t\t\t20170624054836_AWH068C19","doi-asserted-by":"crossref","unstructured":"Floris S, Ruuls SR, Wierinckx A, van der Pol SM, Dopp E, van der Meide PH, et al. Interferon\u2010beta directly influences monocyte infiltration into the central nervous system. J Neuroimmunol2002; 127: 69\u201379.","DOI":"10.1016\/S0165-5728(02)00098-X"},{"key":"key\n\t\t\t\t20170624054836_AWH068C20","doi-asserted-by":"crossref","unstructured":"Gordon EJ, Myers KJ, Dougherty JP, Rosen H, Ron Y. Both anti\u2010CD11a (LFA\u20101) and anti\u2010CD11b (MAC\u20101) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol1995; 62: 153\u201360.","DOI":"10.1016\/0165-5728(95)00120-2"},{"key":"key\n\t\t\t\t20170624054836_AWH068C21","doi-asserted-by":"crossref","unstructured":"Harisinghani MG, Saini S, Weissleder R, Halpern EF, Schima W, Rubin DL, et al. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MRI enhanced with blood\u2010pool contrast agent code\u20107227. Radiology1997; 202: 687\u201391.","DOI":"10.1148\/radiology.202.3.9051017"},{"key":"key\n\t\t\t\t20170624054836_AWH068C22","doi-asserted-by":"crossref","unstructured":"Hawkins CP, Munro PM, MacKenzie F, Kesselring J, Tofts PS, du Boulay EP, et al. Duration and selectivity of blood\u2010brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium\u2010DTPA and protein markers. Brain1990; 113: 365\u201378.","DOI":"10.1093\/brain\/113.2.365"},{"key":"key\n\t\t\t\t20170624054836_AWH068C23","doi-asserted-by":"crossref","unstructured":"Huitinga I, Damoiseaux JG, Dopp EA, Dijkstra CD. Treatment with anti\u2010CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats. Eur J Immunol1993; 23: 709\u201315.","DOI":"10.1002\/eji.1830230321"},{"key":"key\n\t\t\t\t20170624054836_AWH068C24","doi-asserted-by":"crossref","unstructured":"Hunig T, Wallny HJ, Hartley JK, Lawetzky A, Tiefenthaler G. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J Exp Med1989; 169: 73\u201386.","DOI":"10.1084\/jem.169.1.73"},{"key":"key\n\t\t\t\t20170624054836_AWH068C25","doi-asserted-by":"crossref","unstructured":"Juhler M, Barry DI, Offner H, Konat G, Klinken L, Paulson OB. Blood\u2010brain and blood\u2010spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res1984; 302: 347\u2013355.","DOI":"10.1016\/0006-8993(84)90249-X"},{"key":"key\n\t\t\t\t20170624054836_AWH068C26","doi-asserted-by":"crossref","unstructured":"Juhler M, Blasberg RG, Fenstermacher JD, Patlak CS, Paulson OB. A spatial analysis of the blood\u2010brain barrier damage in experimental allergic encephalomyelitis. J Cereb Blood Flow Metab1985; 5: 545\u201353.","DOI":"10.1038\/jcbfm.1985.82"},{"key":"key\n\t\t\t\t20170624054836_AWH068C27","doi-asserted-by":"crossref","unstructured":"Kallmann BA, Hummel V, Lindenlaub T, Ruprecht K, Toyka KV, Rieckmann P. Cytokine\u2010induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule\u20101. Brain2000; 123: 687\u201397.","DOI":"10.1093\/brain\/123.4.687"},{"key":"key\n\t\t\t\t20170624054836_AWH068C28","doi-asserted-by":"crossref","unstructured":"Kappos L, Moeri D, Radue EW, Schoetzau A, Schweikert K, Barkhof F, et al. Predictive value of gadolinium\u2010enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta\u2010analysis. Gadolinium MRI Meta\u2010analysis Group. Lancet1999; 353: 964\u20139.","DOI":"10.1016\/S0140-6736(98)03053-0"},{"key":"key\n\t\t\t\t20170624054836_AWH068C29","doi-asserted-by":"crossref","unstructured":"Karlik SJ, Grant EA, Lee D, Noseworthy JH. Gadolinium enhancement in acute and chronic\u2010progressive experimental allergic encephalomyelitis in the guinea pig. Magn Reson Med1993; 30: 326\u201331.","DOI":"10.1002\/mrm.1910300308"},{"key":"key\n\t\t\t\t20170624054836_AWH068C30","doi-asserted-by":"crossref","unstructured":"Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol1993; 34: 661\u20139.","DOI":"10.1002\/ana.410340507"},{"key":"key\n\t\t\t\t20170624054836_AWH068C31","doi-asserted-by":"crossref","unstructured":"Kermode AG, Tofts PS, Thompson AJ, MacManus DG, Rudge P, Kendall BE, et al. Heterogeneity of blood\u2010brain barrier changes in multiple sclerosis: an MRI study with gadolinium\u2010DTPA enhancement. Neurology1990; 40: 229\u201335.","DOI":"10.1212\/WNL.40.2.229"},{"key":"key\n\t\t\t\t20170624054836_AWH068C32","doi-asserted-by":"crossref","unstructured":"Koh CS, Gausas J, Paterson PY. Neurovascular permeability and fibrin deposition in the central neuraxis of Lewis rats with cell\u2010transferred experimental allergic encephalomyelitis in relationship to clinical and histopathological features of the disease. J Neuroimmunol1993; 47: 141\u20135.","DOI":"10.1016\/0165-5728(93)90024-S"},{"key":"key\n\t\t\t\t20170624054836_AWH068C33","doi-asserted-by":"crossref","unstructured":"Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med2000; 6: 1399\u2013402.","DOI":"10.1038\/82219"},{"key":"key\n\t\t\t\t20170624054836_AWH068C34","doi-asserted-by":"crossref","unstructured":"Lassmann H, Br\u00fcck W, Lucchinetti C, Rodriguez M. Remyelination in multiple sclerosis. Mult Scler1997; 3: 133\u20136.","DOI":"10.1177\/135245859700300213"},{"key":"key\n\t\t\t\t20170624054836_AWH068C35","unstructured":"Lou J, Gasche Y, Zheng L, Giroud C, Morel P, Clements J, et al. Interferon\u2010beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer. Lab Invest1999; 79: 1015\u201325."},{"key":"key\n\t\t\t\t20170624054836_AWH068C36","doi-asserted-by":"crossref","unstructured":"Mato M, Ookawara S, Sakamoto A, Aikawa E, Ogawa T, Mitsuhashi U, et al. Involvement of specific macrophage\u2010lineage cells surrounding arterioles in barrier and scavenger function in brain cortex. Proc Natl Acad Sci USA1996; 93: 3269\u201374.","DOI":"10.1073\/pnas.93.8.3269"},{"key":"key\n\t\t\t\t20170624054836_AWH068C37","doi-asserted-by":"crossref","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50: 121\u20137.","DOI":"10.1002\/ana.1032"},{"key":"key\n\t\t\t\t20170624054836_AWH068C38","doi-asserted-by":"crossref","unstructured":"Miller A, Lanir N, Shapiro S, Revel M, Honigman S, Kinarty A, et al. Immunoregulatory effects of interferon\u2010beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases. J Neuroimmunol1996; 64: 151\u201361.","DOI":"10.1016\/0165-5728(95)00164-6"},{"key":"key\n\t\t\t\t20170624054836_AWH068C39","doi-asserted-by":"crossref","unstructured":"Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, et al. A controlled trial of natalizumab for relapsing multiple sclerosis. New Engl J Med2003; 348: 15\u201323.","DOI":"10.1056\/NEJMoa020696"},{"key":"key\n\t\t\t\t20170624054836_AWH068C40","doi-asserted-by":"crossref","unstructured":"Moor AC, De Vries HE, de Boer AG, Breimer DD. The blood\u2010brain barrier and multiple sclerosis. Biochem Pharmacol1994; 47: 1717\u201324.","DOI":"10.1016\/0006-2952(94)90297-6"},{"key":"key\n\t\t\t\t20170624054836_AWH068C41","doi-asserted-by":"crossref","unstructured":"Moore A, Weissleder R, Bogdanov A Jr. Uptake of dextran\u2010coated monocrystalline iron oxides in tumour cells and macrophages. J Magn Reson Imaging1997; 7: 1140\u20135.","DOI":"10.1002\/jmri.1880070629"},{"key":"key\n\t\t\t\t20170624054836_AWH068C42","doi-asserted-by":"crossref","unstructured":"Morrissey SP, Deichmann R, Syha J, Simonis C, Zettl U, Archelos JJ, et al. Partial inhibition of AT\u2010EAE by an antibody to ICAM\u20101: clinico\u2010histological and MRI studies. J Neuroimmunol 1996; 69: 85\u201393.","DOI":"10.1016\/0165-5728(96)00064-1"},{"key":"key\n\t\t\t\t20170624054836_AWH068C43","unstructured":"Muldoon LL, Pagel MA, Kroll RA, Roman\u2010Goldstein S, Jones RS, Neuwelt EA. A physiological barrier distal to the anatomic blood\u2010brain barrier in a model of transvascular delivery. AJNR Am J Neuroradiol1999; 20: 217\u201322."},{"key":"key\n\t\t\t\t20170624054836_AWH068C44","doi-asserted-by":"crossref","unstructured":"Namer IJ, Steibel J, Poulet P, Armspach JP, Mauss Y, Chambron J. In vivo dynamic MR imaging of MBP\u2010induced acute experimental allergic encephalomyelitis in Lewis rat. Magn Reson Med1992; 24: 325\u201334.","DOI":"10.1002\/mrm.1910240213"},{"key":"key\n\t\t\t\t20170624054836_AWH068C45","doi-asserted-by":"crossref","unstructured":"Neuhaus O, Strasser\u2010Fuchs S, Fazekas F, Kieseier BC, Niederwieser G, Hartung HP, et al. Statins as immunomodulators: comparison with interferon\u2010beta 1b in multiple sclerosis. Neurology2002; 59: 990\u20137.","DOI":"10.1212\/WNL.59.7.990"},{"key":"key\n\t\t\t\t20170624054836_AWH068C46","unstructured":"Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. San Diego: Academic Press; 1986."},{"key":"key\n\t\t\t\t20170624054836_AWH068C47","doi-asserted-by":"crossref","unstructured":"Polfliet MM, van de Veerdonk F, Dopp EA, van Kesteren\u2010Hendrikx EM, van Rooijen N, Dijkstra CD, et al. The role of perivascular and meningeal macrophages in experimental allergic encephalomyelitis. J Neuroimmunol2002; 122: 1\u20138.","DOI":"10.1016\/S0165-5728(01)00445-3"},{"key":"key\n\t\t\t\t20170624054836_AWH068C48","doi-asserted-by":"crossref","unstructured":"Prat A, Biernacki K, Wosik K, Antel JP. Glial cell influence on the human blood\u2010brain barrier. Glia2001; 36: 145\u201355.","DOI":"10.1002\/glia.1104"},{"key":"key\n\t\t\t\t20170624054836_AWH068C49","doi-asserted-by":"crossref","unstructured":"Rausch M, Sauter A, Frohlich J, Neubacher U, Radu EW, Rudin M. Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn Reson Med2001; 46: 1018\u201322.","DOI":"10.1002\/mrm.1290"},{"key":"key\n\t\t\t\t20170624054836_AWH068C50","doi-asserted-by":"crossref","unstructured":"Rausch M, Baumann D, Neubacher U, Rudin M. In\u2010vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed. 2002; 15: 278\u201383.","DOI":"10.1002\/nbm.770"},{"key":"key\n\t\t\t\t20170624054836_AWH068C51","doi-asserted-by":"crossref","unstructured":"Seeldrayers PA, Syha J, Morrissey SP, Stodal H, Vass K, Jung S, et al. Magnetic resonance imaging investigation of blood\u2010brain barrier damage in adoptive transfer experimental autoimmune encephalomyelitis. J Neuroimmunol 1993; 46: 199\u2013206.","DOI":"10.1016\/0165-5728(93)90250-3"},{"key":"key\n\t\t\t\t20170624054836_AWH068C52","doi-asserted-by":"crossref","unstructured":"Seneterre E, Weissleder R, Jaramillo D, Reimer P, Lee AS, Brady TJ, et al. Bone marrow: ultrasmall superparamagnetic iron oxide for MRI. Radiology1991; 179: 529\u201333.","DOI":"10.1148\/radiology.179.2.2014305"},{"key":"key\n\t\t\t\t20170624054836_AWH068C53","doi-asserted-by":"crossref","unstructured":"Sigal R, Vogl T, Casselman J, Moulin G, Veillon F, Hermans R, et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR)\u2014results of a phase\u2010III multicenter clinical trial. Eur Radiol2002; 12: 1104\u201313.","DOI":"10.1007\/s003300101130"},{"key":"key\n\t\t\t\t20170624054836_AWH068C54","doi-asserted-by":"crossref","unstructured":"Silver N, Lai M, Symms M, Barker G, McDonald I, Miller D. Serial gadolinium\u2010enhanced and magnetization transfer imaging to investigate the relationship between the duration of blood\u2010brain barrier disruption and extent of demyelination in new multiple sclerosis lesions. J Neurol1999; 246: 728\u201330.","DOI":"10.1007\/s004150050442"},{"key":"key\n\t\t\t\t20170624054836_AWH068C55","doi-asserted-by":"crossref","unstructured":"Stanislaus R, Pahan K, Singh AK, Singh I. Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin. Neurosci Lett1999; 269: 71\u201374.","DOI":"10.1016\/S0304-3940(99)00414-0"},{"key":"key\n\t\t\t\t20170624054836_AWH068C56","doi-asserted-by":"crossref","unstructured":"Stanislaus R, Singh AK, Singh I. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. J Neurosci Res2001; 66: 155\u201362.","DOI":"10.1002\/jnr.1207"},{"key":"key\n\t\t\t\t20170624054836_AWH068C57","doi-asserted-by":"crossref","unstructured":"Stanislaus R, Gilg AG, Singh AK, Singh I. Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by Lovastatin. Neurosci Lett2002; 333: 167\u201370.","DOI":"10.1016\/S0304-3940(02)00943-6"},{"key":"key\n\t\t\t\t20170624054836_AWH068C58","doi-asserted-by":"crossref","unstructured":"Sormani MP, Bruzzi P, Comi G, Filippi M. MRI metrics as surrogate markers for clinical relapse rate in relapsing\u2010remitting multiple sclerosis patients. Neurology2002; 58: 417\u201321.","DOI":"10.1212\/WNL.58.3.417"},{"key":"key\n\t\t\t\t20170624054836_AWH068C59","doi-asserted-by":"crossref","unstructured":"Tofts PS. Modeling tracer kinetics in dynamic Gd\u2010DTPA MR imaging. J Magn Reson Imaging1997; 7: 91\u2013101.","DOI":"10.1002\/jmri.1880070113"},{"key":"key\n\t\t\t\t20170624054836_AWH068C60","doi-asserted-by":"crossref","unstructured":"Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MRI. Radiology1990; 175: 494\u20138.","DOI":"10.1148\/radiology.175.2.2326475"},{"key":"key\n\t\t\t\t20170624054836_AWH068C61","doi-asserted-by":"crossref","unstructured":"Werring DJ, Brassat D, Droogan AG, Clark CA, Symms MR, Barker GJ, et al. The pathogenesis of lesions and normal\u2010appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain2000; 123: 1667\u201376.","DOI":"10.1093\/brain\/123.8.1667"},{"key":"key\n\t\t\t\t20170624054836_AWH068C62","doi-asserted-by":"crossref","unstructured":"Xu S, Jordan EK, Brocke S, Bulte JW, Quigley L, Tresser N, et al. Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION\u201046L enhanced in vivo MRI: early histopathological correlation. J Neurosci Res1998; 52: 549\u201358.","DOI":"10.1002\/(SICI)1097-4547(19980601)52:5<549::AID-JNR7>3.0.CO;2-C"},{"key":"key\n\t\t\t\t20170624054836_AWH068C63","doi-asserted-by":"crossref","unstructured":"Yednock TA, Cannon C, Fritz LC, Sanchez\u2010Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against \u03b14 \u03b21 integrin. Nature1992; 356: 63\u20136.","DOI":"10.1038\/356063a0"},{"key":"key\n\t\t\t\t20170624054836_AWH068C64","doi-asserted-by":"crossref","unstructured":"Youssef S, Stuve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, et al. The HMG\u2010CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature2002; 420: 78\u201384.","DOI":"10.1038\/nature01158"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/127\/3\/616\/17868933\/awh068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T02:37:05Z","timestamp":1585622225000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awh068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,3]]},"published-print":{"date-parts":[[2004,3]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awh068","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}